Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 4,066 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Basic Unmet Material Needs, Patient Satisfaction, Receipt of Community Resources, Provider Referrals
Interventions: WE CARE; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 2 Months to 10 Years
Enrollment: 1,872 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer Surveillance
Interventions: Patient SOGI Self-Report, SOGI Resource for Clinical Care Education (SORCE), Cancer Center Care Environment; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Physical Activity
Interventions: Mobile STRIDES app (psychoeducation features), Mobile STRIDES app (self-regulation features), Mobile STRIDES app (social support training features); Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Evaluate Accuracy 24 Dietary Recall
Interventions: No intervention (observational study); Other
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Safety, Acceptability
Interventions: High Eudragit® Content Vaginal Film, Low Eudragit® Content Vaginal Film; Device
Lead sponsor: Katherine Bunge; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: The immersive 360-degree educational video, The slideshow (PowerPoint) educational presentation; Other
Lead sponsor: Hunter College of City University of New York; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Fairfield, Connecticut • New York, New York

Conditions: Scar
Interventions: Micro biopsy, Lidocaine with epinephrine; Device · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pregnancy Early, Nausea Gravidarum, Vomiting of Pregnancy
Interventions: Probiotic 10 (Nature's Bounty); Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older · Female only
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Opioid Use Disorder, Opioid Overdose
Interventions: Bundled intervention (Experimental), control group, Buprenorphine (Experimental), Scheduled Peer Support Specialist (Experimental), Telemedicine Buprenorphine Treatment; Other · Drug · Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Second Hand Tobacco Smoke, Nicotine Dependence
Interventions: Clinic Quality Improvement + Behavioral Counseling, Clinic Quality Improvement + Attention Control; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older
Enrollment: 327 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 4
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity
Interventions: CBT with peer-enhanced activities, CBT with supervised aerobic exercise; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 13 Years to 16 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Depressive Disorder, Major
Interventions: SAGE-217, Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 543 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 39
States / cities: Rogers, Arkansas • Bellflower, California • Garden Grove, California + 34 more

Conditions: Obesity, Overweight, Weight Loss
Interventions: Weight Management Intervention; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Freeport, Illinois • Hillsboro, Illinois • Marshall, Illinois

Conditions: Colorectal Cancer, Dysgeusia, Oral Complications of Chemotherapy
Interventions: questionnaire administration, quality-of-life assessment, laboratory biomarker analysis, bovine lactoferrin; Other · Procedure · Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Medical Abortion
Interventions: Self-assessment: MLPT, Self-assessment: LSPT; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cancer Survivors, Cancer of Breast, Body Weight, Overweight and Obesity
Interventions: Behavioral Weight-loss Program Via Telehealth, Behavioral Weight-Loss Program Via Telehealth - Weight Measures, Validated Surveys of Patient-Reported Outcomes; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiovascular Disease, Cancer, Obesity
Interventions: online social network enrollment plus education and self monitoring, Web education control; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 17 Years to 24 Years · Female only
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Chronic Kidney Disease(CKD)
Interventions: SystemCHANGE (TM), Attention Control; Behavioral · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Simtuzumab; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 6
States / cities: Scottsdale, Arizona • Los Angeles, California • Stanford, California + 3 more

Conditions: Cigarette Smoking-Related Carcinoma
Interventions: Smartphone App-delivered Smoking Cessation Intervention, Health Promotion and Education, Biospecimen Collection, Questionnaire Administration; Behavioral · Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years to 30 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Overweight and Obesity
Interventions: AVOID, RESIST; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Beverly Hills, California

Conditions: Overweight, Obesity
Interventions: Phone-based sessions (28 total) on a structured schedule, Phone-based sessions upon request, Weight self-monitoring, Dietary and physical activity self-monitoring, Scheduled tailored interventionist feedback, Dietary goals, Meal replacements, Physical activity goals, Toolbox, Challenges, Tailored interventionist feedback upon request; Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis
Interventions: CYT387; Drug
Lead sponsor: Sierra Oncology LLC - a GSK company; Industry
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 3
States / cities: Stanford, California • Boston, Massachusetts • Rochester, Minnesota

Conditions: Pediatric Cancer
Interventions: Cancer Care Companion; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices

Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation

Mobile Supportive Teams for Reinforcing Increased Daily Exercise Study

Controlled Feeding With 24 Hour Recall

Randomized Cross-Over Study of Self-Insertion of Two Placebo Vaginal Film Formulations

Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity

Reducing Side-effects of Autologous Skin Tissue Harvesting

A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy

A Bundled Intervention to End Opioid Overdoses

Kids Safe and Smokefree (KiSS)

Peer-enhanced Intervention to Support Teen Weight Loss

A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

EMPOWER Rural Extension Weight Management Pilot Study

Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy

Medical Abortion Self-Confirmation (MASC)

Telehealth Weight Loss Program for Breast Cancer Survivors

Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity

Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study

Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)

EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico

CHOICE to AVOID or RESIST

Dissemination of the Look Ahead Weight Management Treatment in the Military

Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)

Cancer Care Companion